
ASCO 2019: The eight biggest stories on anticancer agents
Here is ecancer’s speedy recap on the presentations from the 2019 American Society of Clinical…
Here is ecancer’s speedy recap on the presentations from the 2019 American Society of Clinical…
With over 2400 abstracts presented at the 2019 American Society of Clinical Oncology (ASCO) Annual…
Affordable Care Act (ACA) Medicaid expansion impact on racial disparities in time to cancer treatment…
The New England Journal of Medicine recently published the primary endpoint of the NRG Oncology clinical…
A novel gene therapy clinical trial at University Hospitals Seidman Cancer Center and the Case…
New information about adjuvant therapy to prevent recurrence of breast cancer in women 50 years…
The E2810 research study was conducted to determine whether taking the oral drug pazopanib following…
Treatment with dabrafenib and trametinib, a drug combination designed to target cancers that harbour certain…
A recent, updated predictive analysis of the three WHO-defined molecular subgroups based on isocitrate dehydrogenase…
Results from the phase III NRG Oncology clinical trial GOG 0261 comparing paclitaxel plus carboplatin…